Cambrex High Point
Cambrex High Point (United States) is linked to 1 FDA-registered manufacturing site. No FDA recall, Warning Letter or Form 483 record is linked to it, which is not proof that none exists.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “Cambrex High Point: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/cambrex-high-point
Overview
Cambrex High Point, a subsidiary of Cambrex Corporation, is a leading provider of active pharmaceutical ingredients (APIs), advanced intermediates, and drug product services for the pharmaceutical industry. The company specializes in manufacturing and development services to accelerate drug development and commercialization.
Core services & business areas
Therapeutic areas
Registered manufacturing sites (1)
Physical sites registered with the US FDA and resolved to Cambrex High Point, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Cambrex High Point in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.
Is this Cambrex High Point?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.